Pharma

By Jonah Comstock June 28, 2017
Baltimore-based emocha Mobile Health has been awarded a $1.7 million Fast Track Small Business Innovation Research award by the National Institute on Drug Abuse (NIDA). The company will use the grant for a feasibility study of its digital direct observation therapy tech. Emocha is an acronym for “electronic mobile comprehensive health application”. The company has been developing an app for...
By Jonah Comstock June 26, 2017
The Clinical Trials Transformation Initiative (CTTI), a public-private partnership of pharma companies, academics, and regulators, including FDA, looking to create a new “gold standard” of clinical trial design using digital technology, released new endpoint recommendations today focused on the use of mobile technology in clinical trials.  “By engaging with experts who have been early champions...
By Jonah Comstock June 21, 2017
Madison, Wisconsin-based Propeller Health is now a decade old. The digital health company, which makes connected inhalers and patient- and provider-facing data analytics tools for respiratory diseases asthma and COPD, can hardly be considered a startup anymore. Nowadays the company has numerous published efficacy studies and business relationships with most major pharma companies in the...
By Jonah Comstock June 16, 2017
Bayer recently received FDA approval for a connected auto-injector for relapsing-remitting multiple sclerosis medication and companion app. The device is called the Betaconnect Electronic Autoinjector and the app, due out in July, is myBetaApp. The Whippany, New Jersey-based pharma company didn't clear the app and device through the 510(k) medical device pathway; instead the agency approved a...
By Jonah Comstock May 23, 2017
One year after the FDA declined to approve Proteus Digital Health and Otsuka's new sensor-embedded formulation of Otsuka's antipsychotic drug Abilify, the companies are giving it another shot, resubmitting the application with additional information. As before, the application is a New Drug Application (NDA) -- both the Proteus system itself and Abilify are already FDA cleared and approved,...
By Jonah Comstock May 8, 2017
Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson & Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company Nippon Shinyaku, and an app for...
By Jonah Comstock May 5, 2017
Crystal Lake, Illinois-based Aptar Pharma is teaming up with digital health startup Kali Care to develop a new way of measuring adherence to eye drops in clinical trials.  Because they are somewhat onerous to use, eye drops have even lower rates of adherence than other medications. Kali Care, based in Silicon Valley, makes a small sensor that can be installed in a container for eye drop...
By Heather Mack May 2, 2017
Seattle, Washington-based Pillsy has officially launched its digital medication adherence and tracking tool, which consists of a smart pill bottle and companion app. PillsyCap, as the product is known, uses Bluetooth to sense when the bottle is opened and closed, and syncs with the app to automatically tracks when a user takes their pills, reminds them when they forget a dose or warns if multiple...
By Jonah Comstock April 24, 2017
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced last week its plans to acquire Mytrus, a clinical trial technology company focused on patient-focused electronic informed consent and remote trials. The terms of the acquisition were not disclosed. “The informed consent process is one of the most important parts of running...
By Jonah Comstock April 19, 2017
The first quarter of 2017 saw pharma’s visible participation in digital health steadily ramping up. From partnerships that augment digital diabetes care to infant sleep coaching collaborations, we've covered quite a range of pharma-focused news in Q1. Read on for our list of the digital undertakings of Roche, Takeda, UCB, Johnson & Johnson, and many more.  Boehringer Ingelheim partnered with...

Editor's Pick